Adipogenesis and fat-cell function in obesity and diabetes

被引:173
作者
Camp, HS
Ren, DL
Leff, T
机构
[1] Pfizer Global Res & Dev, Dept Mol Sci & Technol, Ann Arbor, MI 48105 USA
[2] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
[3] Wayne State Univ, Sch Med, Ctr Integrat Metab & Endocrine Res, Detroit, MI 48201 USA
关键词
D O I
10.1016/S1471-4914(02)02396-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Normal metabolic balance is maintained by a complex homeostatic system involving multiple tissues and organs. Acquired or inherited defects in any part of this system can lead to metabolic disorders, such as diabetes and obesity. Adipose tissue, once thought to function primarily as a passive depot for the storage of excess lipid, is now understood to play a much more active role in metabolic regulation, secreting a variety of metabolic hormones and actively functioning to prevent deleterious lipid accumulation in other tissues. Here, we review new advances in our understanding of adipogenesis and fat-cell function, primarily from the perspective of the transcription factor peroxisome proliferator-activated receptor gamma.
引用
收藏
页码:442 / 447
页数:6
相关论文
共 65 条
  • [1] A novel heterozygous mutation in peroxisome proliferator-activated receptor-γ gene in a patient with familial partial lipodystrophy
    Agarwal, AK
    Garg, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) : 408 - 411
  • [2] Efficacy of troglitazone on body fat distribution in type 2 diabetes
    Akazawa, S
    Sun, FY
    Ito, M
    Kawasaki, E
    Eguchi, K
    [J]. DIABETES CARE, 2000, 23 (08) : 1067 - 1071
  • [3] PPAR gamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A
    Altiok, S
    Xu, M
    Spiegelman, BM
    [J]. GENES & DEVELOPMENT, 1997, 11 (15) : 1987 - 1998
  • [4] Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans - No alteration in adipose tissue of obese and NIDDM patients
    Auboeuf, D
    Rieusset, J
    Fajas, L
    Vallier, P
    Frering, V
    Riou, JP
    Staels, P
    Auwerx, J
    Laville, M
    Vidal, H
    [J]. DIABETES, 1997, 46 (08) : 1319 - 1327
  • [5] PPARγ is required for placental, cardiac, and adipose tissue development
    Barak, Y
    Nelson, MC
    Ong, ES
    Jones, YZ
    Ruiz-Lozano, P
    Chien, KR
    Koder, A
    Evans, RM
    [J]. MOLECULAR CELL, 1999, 4 (04) : 585 - 595
  • [6] The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
    Berg, AH
    Combs, TP
    Du, XL
    Brownlee, M
    Scherer, PE
    [J]. NATURE MEDICINE, 2001, 7 (08) : 947 - 953
  • [7] POSTRECEPTOR DEFECTS CAUSING INSULIN RESISTANCE IN NORMOINSULINEMIC NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    BOLINDER, J
    OSTMAN, J
    ARNER, P
    [J]. DIABETES, 1982, 31 (10) : 911 - 916
  • [8] Visceral adiposity and risk of type 2 diabetes - A prospective study among Japanese Americans
    Boyko, EJ
    Fujimoto, WY
    Leonetti, DL
    Newell-Morris, L
    [J]. DIABETES CARE, 2000, 23 (04) : 465 - 471
  • [9] Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy
    Cao, H
    Hegele, RA
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (01) : 109 - 112
  • [10] Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs
    Chen, PL
    Riley, DJ
    Chen, YM
    Lee, WH
    [J]. GENES & DEVELOPMENT, 1996, 10 (21) : 2794 - 2804